Thomas Sparre

964 total citations
46 papers, 661 citations indexed

About

Thomas Sparre is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, Thomas Sparre has authored 46 papers receiving a total of 661 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Endocrinology, Diabetes and Metabolism, 19 papers in Surgery and 19 papers in Genetics. Recurrent topics in Thomas Sparre's work include Diabetes Management and Research (22 papers), Diabetes and associated disorders (19 papers) and Pancreatic function and diabetes (19 papers). Thomas Sparre is often cited by papers focused on Diabetes Management and Research (22 papers), Diabetes and associated disorders (19 papers) and Pancreatic function and diabetes (19 papers). Thomas Sparre collaborates with scholars based in Denmark, United States and Sweden. Thomas Sparre's co-authors include Jørn Nerup, Flemming Pociot, Peter Roepstorff, Allan E. Karlsen, Stephen J. Fey, Peter Mose Larsen, Martin R. Larsen, Jonas Kildegaard, Thomas Mandrup‐Poulsen and Sibylle Dellweg and has published in prestigious journals such as Diabetes Care, Biochemical and Biophysical Research Communications and Diabetologia.

In The Last Decade

Thomas Sparre

44 papers receiving 618 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Thomas Sparre Denmark 16 252 214 190 178 113 46 661
Lars Hansen Denmark 14 285 1.1× 279 1.3× 233 1.2× 360 2.0× 23 0.2× 32 829
Mercè Garcia-Barceló Hong Kong 17 416 1.7× 48 0.2× 165 0.9× 284 1.6× 31 0.3× 26 881
D. J. Pillion United States 15 121 0.5× 144 0.7× 52 0.3× 203 1.1× 30 0.3× 22 500
Dimitar Gavrilov United States 15 74 0.3× 39 0.2× 121 0.6× 403 2.3× 200 1.8× 35 901
Guoqiang Xu China 15 186 0.7× 41 0.2× 60 0.3× 176 1.0× 22 0.2× 43 686
Şeyma Hasçalık Türkiye 15 84 0.3× 51 0.2× 42 0.2× 62 0.3× 59 0.5× 52 634
Chih‐Jen Cheng Taiwan 17 106 0.4× 134 0.6× 46 0.2× 570 3.2× 40 0.4× 44 831
John Fernandes Netherlands 11 95 0.4× 34 0.2× 148 0.8× 179 1.0× 71 0.6× 16 631
Shawn E. McCandless United States 17 81 0.3× 55 0.3× 277 1.5× 495 2.8× 299 2.6× 34 1.2k
Luigi Garibaldi United States 17 62 0.2× 323 1.5× 181 1.0× 219 1.2× 74 0.7× 43 662

Countries citing papers authored by Thomas Sparre

Since Specialization
Citations

This map shows the geographic impact of Thomas Sparre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Sparre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Sparre more than expected).

Fields of papers citing papers by Thomas Sparre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Sparre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Sparre. The network helps show where Thomas Sparre may publish in the future.

Co-authorship network of co-authors of Thomas Sparre

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Sparre. A scholar is included among the top collaborators of Thomas Sparre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Sparre. Thomas Sparre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Akhtar, Shahid, et al.. (2025). Ease of Use of the Reusable DuraTouch Pen Injector in Individuals with Diabetes with and Without Previous Pen Injector Experience: A Handling Study. Diabetes Technology & Therapeutics. 28(1). 68–72. 1 indexed citations
2.
Rasmussen, Niklas Kahr, et al.. (2024). The Concizumab Pen-Injector is Easy to Use and Preferred by Hemophilia Patients and Caregivers: A Usability Study Assessing Pen-Injector Handling and Preference. Patient Preference and Adherence. Volume 18. 1713–1727. 4 indexed citations
3.
Poulsen, Mette H., et al.. (2024). The Needle Shield Size and Applied Force of Subcutaneous Autoinjectors Significantly Influence the Injection Depth. Journal of Diabetes Science and Technology. 19(5). 1317–1325. 3 indexed citations
4.
Rasmussen, Niklas Kahr, et al.. (2023). PB0635 A Usability Study Assessing Handling and Preference of the Concizumab Pen-Injector in Patients with Haemophilia and Caregivers. Research and Practice in Thrombosis and Haemostasis. 7. 101193–101193. 1 indexed citations
5.
Sparre, Thomas, et al.. (2022). Factors Affecting Performance of Insulin Pen Injector Technology: A Narrative Review. Journal of Diabetes Science and Technology. 17(2). 290–301. 10 indexed citations
6.
Sparre, Thomas, et al.. (2021). Development of an Insulin Pen is a Patient-Centric Multidisciplinary Undertaking: A Commentary. Journal of Diabetes Science and Technology. 16(3). 617–622. 4 indexed citations
8.
Rønn, Birgitte, et al.. (2017). FlexTouch: An Insulin Pen-Injector with a Low Activation Force Across Different Insulin Formulations, Needle Technologies, and Temperature Conditions. Diabetes Technology & Therapeutics. 19(10). 603–607. 9 indexed citations
9.
Korsatko, Stefan, Gerd Köhler, Andrea Wutte, et al.. (2009). The effect of terbutaline on the absorption of pulmonary administered insulin in subjects with asthma. British Journal of Clinical Pharmacology. 69(3). 271–278. 5 indexed citations
10.
Reusens, Brigitte, Thomas Sparre, Thomas Bouckenooghe, et al.. (2008). The intrauterine metabolic environment modulates the gene expression pattern in fetal rat islets: prevention by maternal taurine supplementation. Diabetologia. 51(5). 836–845. 37 indexed citations
11.
Møller, Morten, Thomas Sparre, Nicolai Bache, Peter Roepstorff, & Henrik Vorum. (2007). Proteomic analysis of day–night variations in protein levels in the rat pineal gland. PROTEOMICS. 7(12). 2009–2018. 32 indexed citations
12.
Karlsen, Allan E., Zenia M. Størling, Thomas Sparre, et al.. (2006). Immune-mediated β-cell destruction in vitro and in vivo—A pivotal role for galectin-3. Biochemical and Biophysical Research Communications. 344(1). 406–415. 34 indexed citations
13.
Bergholdt, Regine, et al.. (2006). Identification and Characterization of Secretagogin Promoter Activity. Scandinavian Journal of Immunology. 64(6). 639–645. 12 indexed citations
14.
Sparre, Thomas, Marie‐Thérèse Ahn, Torben Ørntoft, et al.. (2005). Nutritional regulation of proteases involved in fetal rat insulin secretion and islet cell proliferation. British Journal Of Nutrition. 93(3). 309–316. 10 indexed citations
15.
Sparre, Thomas, et al.. (2005). Anaesthesia-induced hyperglycaemia early in life is not predictive for development of diabetes in diabetes-prone BB rats. Acta Diabetologica. 42(2). 95–98. 1 indexed citations
16.
Nerup, Jørn, Thomas Sparre, C. F. Gotfredsen, et al.. (2004). Changes in expression of IL-1� influenced proteins in transplanted islets during development of diabetes in diabetes-prone BB rats. Diabetologia. 47(5). 892–908. 24 indexed citations
17.
Nielsen, Kristina Tomra, et al.. (2004). Gene expression profiles during beta cell maturation and after IL-1? exposure reveal important roles of Pdx-1 and Nkx6.1 for IL-1? sensitivity. Diabetologia. 47(12). 2185–2199. 21 indexed citations
18.
Sparre, Thomas, Brigitte Reusens, Hanène Chérif, et al.. (2003). Intrauterine programming of fetal islet gene expression in rats?effects of maternal protein restriction during gestation revealed by proteome analysis. Diabetologia. 46(11). 1497–1511. 47 indexed citations
19.
Karlsen, Allan E., Thomas Sparre, Karin Kramer Nielsen, Jørn Nerup, & Flemming Pociot. (2001). Proteome Analysis—A Novel Approach to Understand the Pathogenesis of Type 1 Diabetes Mellitus. Disease Markers. 17(4). 205–216. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026